3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Sjogren's Syndrome
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Interventions
Vincristine
20
Cytarabine
19
Methotrexate
18
Dexamethasone
17
Cyclophosphamide
17
Mercaptopurine
16
Daunorubicin
12
Asparaginase
12
Doxorubicin
10
Prednisolone
9
Granulocyte Colony-Stimulating Factor
8
Idarubicin
7
Etoposide
7
Thioguanine
6
Teniposide
6
Rituximab
6
Prednisone
6
Vindesine
5
Ifosfamide
5
Stem Cell Transplantation
4
fludarabine
3
Mitoxantrone
3
Hydrocortisone
3
pegaspargase
2
Ketamine
2
Inotuzumab Ozogamicin
2
Imatinib Mesylate
2
Cladribine
2
Cholecalciferol
2
pegylated granulocyte colony-stimulating factor
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Precursor Cell Lymphoblastic Leukemia-Lymphoma
×
belimumab
×
Clear all
NCT06410833
2024-05-16
BRRPJS
Peking Union Medical College Hospital
Phase 4
Recruiting
15 enrolled